Tempus AI (NASDAQ:TEM) Shares Gap Up to $50.19

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $50.19, but opened at $51.94. Tempus AI shares last traded at $48.15, with a volume of 176,794 shares traded.

Analyst Ratings Changes

A number of research firms have recently issued reports on TEM. Stifel Nicolaus began coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a "buy" rating and a $45.00 price objective for the company. Needham & Company LLC reaffirmed a "buy" rating and set a $47.00 price objective on shares of Tempus AI in a report on Wednesday, August 7th. JPMorgan Chase & Co. lifted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an "overweight" rating in a report on Wednesday, August 7th. Bank of America began coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a "buy" rating and a $41.00 price objective for the company. Finally, TD Cowen began coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a "buy" rating and a $50.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company's stock. Based on data from MarketBeat, Tempus AI currently has an average rating of "Moderate Buy" and a consensus price target of $45.56.

Tempus AI Stock Performance

The firm's 50-day moving average price is $45.49.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The business had revenue of $165.97 million for the quarter, compared to analysts' expectations of $159.10 million. As a group, analysts forecast that Tempus AI, Inc. will post -6.51 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Tempus AI

Hedge funds and other institutional investors have recently modified their holdings of the stock. Sandia Investment Management LP purchased a new position in shares of Tempus AI during the second quarter valued at about $136,000. Northwestern University purchased a new position in shares of Tempus AI during the second quarter valued at about $491,000. Squarepoint Ops LLC purchased a new position in shares of Tempus AI during the second quarter valued at about $633,000. WINTON GROUP Ltd purchased a new position in shares of Tempus AI during the second quarter valued at about $634,000. Finally, Scientech Research LLC purchased a new position in shares of Tempus AI during the second quarter valued at about $756,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.